These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1077 related items for PubMed ID: 22522940

  • 21. Subthalamic nucleus stimulation does not cause deterioration of preexisting hallucinations in Parkinson's disease patients.
    Yoshida F, Miyagi Y, Kishimoto J, Morioka T, Murakami N, Hashiguchi K, Samura K, Sakae N, Yamasaki R, Kawaguchi M, Sasaki T.
    Stereotact Funct Neurosurg; 2009; 87(1):45-9. PubMed ID: 19174620
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Subthalamic span of beta oscillations predicts deep brain stimulation efficacy for patients with Parkinson's disease.
    Zaidel A, Spivak A, Grieb B, Bergman H, Israel Z.
    Brain; 2010 Jul; 133(Pt 7):2007-21. PubMed ID: 20534648
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Differential effects of levodopa and subthalamic nucleus deep brain stimulation on bradykinesia in Parkinson's disease.
    Timmermann L, Braun M, Groiss S, Wojtecki L, Ostrowski S, Krause H, Pollok B, Südmeyer M, Ploner M, Gross J, Maarouf M, Voges J, Sturm V, Schnitzler A.
    Mov Disord; 2008 Jan 30; 23(2):218-27. PubMed ID: 18044706
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Two-year follow-up on the effect of unilateral subthalamic deep brain stimulation in highly asymmetric Parkinson's disease.
    Kim HJ, Paek SH, Kim JY, Lee JY, Lim YH, Kim DG, Jeon BS.
    Mov Disord; 2009 Feb 15; 24(3):329-35. PubMed ID: 19006187
    [Abstract] [Full Text] [Related]

  • 30. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease.
    Limousin P, Krack P, Pollak P, Benazzouz A, Ardouin C, Hoffmann D, Benabid AL.
    N Engl J Med; 1998 Oct 15; 339(16):1105-11. PubMed ID: 9770557
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Efficacy of bilateral subthalamic nucleus (STN) stimulation in Parkinson's disease.
    Erola T, Heikkinen ER, Haapaniemi T, Tuominen J, Juolasmaa A, Myllylä VV.
    Acta Neurochir (Wien); 2006 Apr 15; 148(4):389-94. PubMed ID: 16284705
    [Abstract] [Full Text] [Related]

  • 36. Two cases of unexpected long-term improvement of Parkinson's disease after subthalamic nucleus deep brain stimulation removal.
    Wong SH, Eldridge PR, Duffy A, Fox SH, Varma TR, Fletcher NA.
    Br J Neurosurg; 2011 Apr 15; 25(2):281-3. PubMed ID: 21344961
    [Abstract] [Full Text] [Related]

  • 37. Subthalamic nucleus stimulation and somatosensory temporal discrimination in Parkinson's disease.
    Conte A, Modugno N, Lena F, Dispenza S, Gandolfi B, Iezzi E, Fabbrini G, Berardelli A.
    Brain; 2010 Sep 15; 133(9):2656-63. PubMed ID: 20802206
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 54.